US: S&P 500 eases after vaccine news rally
[NEW YORK] The S&P 500 dipped at the open on Tuesday as excitement over signs of a first successful late-stage Covid-19 vaccine trial faded, while investors continued to pull money out of the big tech companies that have benefited most from the pandemic.
The Dow Jones Industrial Average rose 96.20 points, or 0.33 per cent, at the open to 29,254.17.
The S&P 500 opened lower by 7.24 points, or 0.20 per cent, at 3,543.26, while the Nasdaq Composite dropped 91.34 points, or 0.78 per cent, to 11,622.44 at the opening bell.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Capital Markets & Currencies
H2G Green chief to stand trial on Aug 5 amid MOM probe
Singapore shares climb at Friday’s open; STI up 0.2%
Stocks to watch: DBS, KIT, Clint, Elite Commercial Reit
Europe: Shares ease after Federal Reserve decision, mixed earnings
US: Tech shares lead stocks higher
NYSE-parent ICE’s revenue misses as muted IPO markets offset record energy trading